203 related articles for article (PubMed ID: 17011541)
1. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.
Bouzas L; Tutor JC
Clin Biochem; 2007 Jan; 40(1-2):132-6. PubMed ID: 17011541
[TBL] [Abstract][Full Text] [Related]
2. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.
Bouzas L; Hermida J; Tutor JC
Ups J Med Sci; 2009; 114(1):55-61. PubMed ID: 19242874
[TBL] [Abstract][Full Text] [Related]
3. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation.
Baldelli S; Crippa A; Gabrieli R; Fiocchi R; Perico N; Merlini S; Ottomano C; Cattaneo D
Clin Biochem; 2006 Dec; 39(12):1152-9. PubMed ID: 17054930
[TBL] [Abstract][Full Text] [Related]
5. Quantification of sirolimus and everolimus by immunoassay techniques: test specificity and cross-reactivity evaluation.
Pieri M; Miraglia N; Gentile A; Polichetti G; Castiglia L; Federico S; Sabbatini M; Basile V; Tarantino G; Acampora A; Capone D
Int J Immunopathol Pharmacol; 2008; 21(3):585-94. PubMed ID: 18831925
[TBL] [Abstract][Full Text] [Related]
6. Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® system.
Hermida-Cadahia EF; Tutor JC
Scand J Clin Lab Invest; 2012 Apr; 72(2):180-3. PubMed ID: 22248047
[TBL] [Abstract][Full Text] [Related]
7. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
Khoschsorur G; Fruehwirth F; Zelzer S; Stettin M; Halwachs-Baumann G
Clin Chim Acta; 2007 May; 380(1-2):217-21. PubMed ID: 17320846
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
Morris RG; Salm P; Taylor PJ; Wicks FA; Theodossi A
Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a microparticle enzyme immunoassay for the measurement of sirolimus in whole blood (Abbott IMx sirolimus).
Scholer A; Von Rickenbach R; Faffa G; Vetter B
Clin Lab; 2006; 52(7-8):325-34. PubMed ID: 16955630
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.
Salm P; Warnholtz C; Boyd J; Arabshahi L; Marbach P; Taylor PJ
Clin Biochem; 2006 Jul; 39(7):732-8. PubMed ID: 16725133
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an immunoassay (Abbott-IMX Analyzer) allowing routine determination of sirolimus: comparison with LC-MS method.
Bargnoux AS; Bonardet A; Chong G; Garrigue V; Deleuze S; Dupuy AM; Mourad G; Cristol JP
Transplant Proc; 2006 Sep; 38(7):2352-3. PubMed ID: 16980087
[TBL] [Abstract][Full Text] [Related]
12. Crossreactivity of isolated everolimus metabolites with the Innofluor Certican immunoassay for therapeutic drug monitoring of everolimus.
Strom T; Haschke M; Boyd J; Roberts M; Arabshahi L; Marbach P; Christians U
Ther Drug Monit; 2007 Dec; 29(6):743-9. PubMed ID: 18043471
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the Abbott IMx sirolimus assay in relation to a high-performance liquid chromatography-ultraviolet method.
Johnson RN; Sargon R; Woollard G; Davidson J
Ann Clin Biochem; 2005 Sep; 42(Pt 5):394-7. PubMed ID: 16168196
[TBL] [Abstract][Full Text] [Related]
14. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
Bouzas L; Ortega FJ; Casado P; Arranz MI; Carcas A; Tutor JC
Clin Lab; 2007; 53(9-12):591-6. PubMed ID: 18257466
[TBL] [Abstract][Full Text] [Related]
15. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.
Wilson D; Johnston F; Holt D; Moreton M; Engelmayer J; Gaulier JM; Luthe H; Marquet P; Moscato D; Oellerich M; Mosso R; Streit F; Brunet M; Fillee C; Schmid R; Wallemacq P; Barnes G
Clin Biochem; 2006 Apr; 39(4):378-86. PubMed ID: 16545357
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis.
Fillée C; Mourad M; Squifflet JP; Malaise J; Lerut J; Reding R; Borghgraef P; Vanbinst R; Wallemacq PE
Transplant Proc; 2005; 37(6):2890-1. PubMed ID: 16182845
[TBL] [Abstract][Full Text] [Related]
18. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
[TBL] [Abstract][Full Text] [Related]
19. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
20. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
Ju MK; Chang HK; Kim HJ; Huh KH; Ahn HJ; Kim MS; Kim SI; Kim YS
Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
